Dr. Reddy's Laboratories Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 25, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
DRL filed a 6-K, just routine paperwork, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 25, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer. This filing is routine and does not disclose specific financial transactions or material events.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is adhering to its reporting obligations as a foreign private issuer, which is standard for companies listed on US exchanges.
Risk Assessment
Risk Level: low — The filing is a standard procedural document for a foreign private issuer and does not contain any new material information that would impact risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-25-000721 (accession_number) — Filing identifier
- 20251125 (date) — Filing date
- 2834 (sic_code) — Pharmaceutical Preparations industry code
- 001-15182 (sec_file_number) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information that the company may be required to make public in its home country or that it may be making public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on November 25, 2025.
What is the principal executive office address of Dr. Reddy's Laboratories Ltd.?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Ltd. indicates it files annual reports under Form 20-F.
What industry is Dr. Reddy's Laboratories Ltd. classified under?
Dr. Reddy's Laboratories Ltd. is classified under the SIC code 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-11-25 06:03:35
Filing Documents
- rdy0823_6k.htm (6-K) — 48KB
- rdy0823_ex99-1.htm (EX-99.1) — 56KB
- rdy0823_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0823_ex99-1img02.jpg (GRAPHIC) — 8KB
- rdy0823_ex99-1img03.jpg (GRAPHIC) — 21KB
- 0001575872-25-000721.txt ( ) — 159KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: November 24, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3